SAM
MEDP icon

Strategy Asset Managers’s Medpace MEDP Stock Holding History

Strategy Asset Managers’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-619
Closed -$297K – 277
2026
Q1 		$297K Sell
619
-4
-0.6% -$2.05K 0.05% 217
2025
Q4 		$350K Buy
623
+170
+38% +$96.5K 0.06% 188
2025
Q3 		$233K Buy
+453
New +$198K 0.04% 236

Other funds holding MEDP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Strategy Asset Managers's MEDP Position: Q2 2026 in Review

Strategy Asset Managers sold out of Medpace (MEDP) in Q2 2026, closing a stake of 619 shares — an estimated $297K sold.

Strategy Asset Managers first reported a position in MEDP in Q3 2025 and held it in 3 quarters. The position peaked at $350K in Q4 2025. 697 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Strategy Asset Managers reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
  • Strategy Asset Managers sold 619 Medpace shares in Q2 2026, an estimated $297K.
  • Strategy Asset Managers first reported a position in Medpace in Q3 2025 and held it in 3 quarters.
  • Strategy Asset Managers's Medpace position peaked at $350K in Q4 2025.
  • 697 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Strategy Asset Managers's 13F filing for Q2 2026, filed 14 Aug 2026.